NVST — Envista Holdings Corp

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1757073 ·
Last close
$24.60
Market Cap
$4.00B
52W High
$29.52
52W Low
$22.35
ADV30
3,723,723
Next earnings
2026-08-05
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 705,500,000 390,100,000 66,200,000 38,700,000 5,578,000,000 1,082,800,000 2,498,500,000
Dec 2025 750,600,000 410,600,000 93,000,000 32,900,000 5,679,000,000 1,211,700,000 2,572,700,000
Sep 2025 669,900,000 370,200,000 57,500,000 -30,300,000 5,642,500,000 1,133,900,000 2,554,300,000
Jun 2025 682,100,000 369,900,000 46,300,000 26,400,000 5,664,400,000 1,110,600,000 2,525,400,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$272,100,000
Investing CF
$-111,200,000
Financing CF
$-198,900,000
CapEx
$-51,900,000
Dividends Paid
Buybacks
$-194,700,000
EPS Diluted TTM
$0.41
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-401,700,000
Inventory
$300,300,000
Receivables
$436,600,000
ST Investments
EBIT TTM
$235,100,000
Pretax Income TTM
$200,400,000
Interest Exp TTM
$34,700,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,808,100,096
EBITDA
$383,100,000
Free Cash Flow
$216,337,504
Enterprise Value
$4,509,507,072
Total Cash
$1,082,800,000
Total Debt
$1,589,200,000
Shares Out
162,727,923
Trailing EPS
$0.41
Book Value
$18.90
ROE
2.2%
ROA
3.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,719,500,000 235,800,000 47,000,000 5,679,000,000 2,572,700,000 275,700,000
Dec 2024 2,510,600,000 137,200,000 -1,118,600,000 5,350,500,000 2,415,700,000 336,500,000
Dec 2023 2,566,500,000 314,900,000 -100,200,000 6,605,100,000 2,431,200,000 275,700,000
Dec 2022 2,569,100,000 343,200,000 243,100,000 6,587,000,000 2,380,100,000 182,700,000

TTM Snapshot

Revenues TTM
$2,470,700,000
NetIncome TTM
$170,200,000
OpCashFlow TTM
$0
Assets (Latest)
$5,350,500,000
Forward EPS
$1.57

Max Pain — expiry 2026-06-18

max pain strike: $25.00 · spot: $24.77 · call oi: 5,609 · put oi: 1,081
Expected Move to 2026-06-18: ±$0.88 (3.53%) — implied range $23.90$25.65 · ATM straddle on $25.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MMSI MERIT MEDICAL SYSTEMS INC $3.97B $66.53
MMED MiniMed Group, Inc. $4.26B $15.16
IRTC iRhythm Holdings, Inc. $3.73B $113.65
LIVN LivaNova PLC $4.36B $79.39
ICUI ICU MEDICAL INC/DE $3.55B $142.20

News headlines (Yahoo Finance, 1h cache)

Here's Why You Should Retain NVST Stock in Your Portfolio for Now
2026-06-08 15:49 · Yahoo
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Avoid
2026-06-05 18:16 · Yahoo
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
2026-06-05 15:30 · Yahoo
3 Stocks Under $50 That Concern Us
2026-06-04 23:41 · Yahoo
Is NVST Attractive at 15.1x Forward Earnings?
2026-06-04 15:51 · Yahoo
NVST Stock Explained for 2026 Growth Drivers and Risks
2026-06-03 15:16 · Yahoo
1 Profitable Stock to Keep an Eye On and 2 We Avoid
2026-05-25 09:07 · Yahoo
The Bull Case For Envista Holdings (NVST) Could Change Following New Small-Cap Fund Backing And Margin Focus
2026-05-23 01:15 · Yahoo
Aristotle Small Cap Equity Fund Picked Envista Holdings (NVST) Citing Varied Growth Signals
2026-05-21 14:46 · Yahoo
3 Healthcare Stocks with Open Questions
2026-05-18 09:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.